Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.
Recent amendments to a California bill that seeks to place restrictions on the sale of some weight management supplements to minors removed retail access restrictions and clarifies definitions, leading one trade association to remove its objections.
Mandatory Product Listing can still be a good idea for industry, proponents maintain, even if the latest legislative iteration has failed to garner support from stakeholders.
Three trade organizations joined forces in opposing the FDA Safety and Landmark Advancement Act of 2022 (FDASLA), a fee authorization bill that includes provisions aimed at tightening dietary supplement regulations.
Amendments offered by Sen. Mitt Romney, R-UT, could soften some of the hardest edges in an FDA fee reauthorization bill that includes language meant to tighten the regulation of dietary supplements. But the bill still sets a very troubling precedent,...
A controversial California bill that seeks to place restrictions on the sale of some weight management supplements to minors has been amended but is still alive in the state's legislature.
Weight-loss testimonials "are not adequate substantiation" to prove diets work and specific food references require authorised health claims, the UK Advertising Standards Authority (ASA) has said in a guidance statement.
A bill to restrict some supplement sales has passed the Rhode Island State Senate by an overwhelming vote. The bill remains to be taken up by the state House before the legislature closes shop for the summer on June 30.
The US Food & Drug Administration intends to release multiple draft guidance documents to the industry as smaller, discreet topics relating to New Dietary Ingredients (NDI), a senior figure said recently.
Authors of a bipartisan bill to reauthorize FDA user fees have included provisions bearing on dietary supplements, which has stirred up a hornets nest within the industry.
Lead scientist Richard van Breemen, along with his co-founder and CEO Jacob Crabtree joined us to discuss the research that caught the world’s attention.
EFSA’s decision this week to stop the clock on 150 CBD (cannabidiol) Novel Food applications and publish a litany of ‘data gaps’ does not threaten thousands of on-market CBD products in the UK, its Food Standards Agency (FSA) has told NutraIngredients.
The European Food Safety Authority (EFSA) has issued a wide-ranging opinion calling for more safety data for CBD products that could challenge the Novel Foods status of many offerings in the nascent category across the bloc and beyond.
Procter & Gamble has succeeded in forcing competitor DSM to agree to drop most of the health claims connected to its Culturelle IBS Complete Support product.
A new report from the Centers of Disease Control has found that annual number of pediatric ingestions of melatonin reported to poison control centers increased 530% from 2012 to 2021.
The return of the IPA World Congress + Probiota Americas is just over a week away. Don’t wait to register your attendance for this world-class program in Washington, D.C.
The return of the IPA World Congress + Probiota Americas is just one week away. With key scientific insights into one of the industry’s hottest topics, stress management and sleep, register today! Snooze and you lose…
The return of the IPA World Congress + Probiota Americas is just over a week away. Don’t wait to register for this world-class program in Washington, D.C.
The US Federal Trade Commission is proposing an updated set of rules that would attempt to rein in the burgeoning use of phony reviews to hawk products online. They would also work to prevent the suppression of negative reviews
A mandatory product listing of the sort proposed in a recent bill sponsored by Sen. Dick Durbin, D-IL, would give an illusion of control of the dietary supplement marketplace without better protecting consumers, a prominent industry critic alleges.
A panel of regulatory experts will examine some of the pressing issues in the probiotics filed at the upcoming Probiota Americas event. Questions about New Dietary Ingredients notifications, labeling issues, expanding health indications for probiotics...
FDA announced today that intends to exercise enforcement discretion on missing New Dietary Ingredient Notifications. The Agency also set up a new portal to allow companies to more easily come into compliance by filing the notifications that they should...
In a coordinated enforcement action, FDA has sent warning letters to 10 dietary supplement companies using ingredients that have been added to its Ingredients Advisory List.
The Federal Trade Commission is returning $149 million to consumers who lost money acting as distributors for Advocare, a former multi level marketing company deemed by regulators to have been an illegal pyramid scheme.
A World Health Organization (WHO) report claims that pregnant women and mothers are being targeted online by formula milk companies with personalised social media content.
The European Food Safety Authority (EFSA) has given the thumbs up to extending the use of Bimuno’s galactooligosaccharises (GOS) as a novel food for use in special medical purposes (FSMP).
FDA came down hard on purveyors of Delta-8 THC and CBD products that were making disease claims on the substances. The Agency also reiterated the reasons it believes Delta-8 is not a suitable ingredient for products marketed as supplements.
FDA has issued a draft guidance on how to accredit foreign certifying bodies. The document will help clarify a highly technical aspect of the Food Safety and Modernization Act and will remind dietary supplement firms that it’s high time to get their...
China’s food regulator is seeking public consultation on the use of the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) in infant formula as well as in foods for toddlers and young children.
FDA’s recently announced enforcement discretion policy on NAC will bring some certainty to the market. But it doesn’t answer all of the questions surrounding the ingredient, which could cause other issues later, experts said.
This week, Senators Durbin (D-IL) and Braun (R-IN) introduced S. 4090, the Dietary Supplement Listing Act of 2022, on a bipartisan basis. The legislation would create a mandatory product listing for dietary supplements, similar to the voluntary Supplement...
The Natural Products Association has sent a letter to Senators Dick Durbin and Mike Braun extensively rebutting assertions made in support of their bill that requires mandatory product listing for dietary supplements.
The IPA World Congress + Probiota Americas 2022 is just over a month away! The leading event for the probiotics, prebiotics, and microbiome community is a must-attend event, and let us tell you why…
Larisa Pavlick has devoted her entire career to the supplement industry. She spent nearly a decade at FDA focused on consumer safety and also experienced the full product life cycle from the development phase, through purchasing, into manufacturing, brand...
A bill to require mandatory product listing for supplement manufacturers is set for introduction, according a speech yesterday by Sen. Dick Durbin, D-IL.
Amarin Pharma Inc., manufacturer of omega-3 drug Vascepa, was only partially successful in getting a fish oil supplements company to drop some claims in an advertising challenge.
The dietary supplements industry has been paying tribute to the Senator Orrin Hatch, who passed away on Saturday, April 23, 2022 in Salt Lake City, Utah at the age of 88.
NutraIngredients took the opportunity to speak to Magali Cordaillat-Simmons, Scientific and Regulatory Affairs Director, Pharmabiotic Research Institute (PRI) on regulatory science and how it paves the way for innovative therapies.
A new FDA draft guidance on food allergens lays out the factors the Agency will use to evaluate the risk posed by substances beyond the nine major allergens now on or soon to be added to the list.
The US Food and Drug Administration declared today that it will exercise enforcement discretion on the use of NAC. It also said that it is ‘likely’ to make a rule that would formalize the legal use of the compound in finished dietary supplements.
The Senate candidacy of Dr Mehmet Oz, MD, could pose a public relations risk for the dietary supplement industry, as the prominent media personality gets attacked for being a ‘quack’ who has promoted questionable products.
